The Access Consortium comprises the medicine and healthcare regulatory agencies of Australia, Canada, the UK, Singapore and Switzerland. This updated strategic plan outlines the Consortium's approach to regulatory collaboration, streamlined processes and improved access to safe and effective medicines. 

Key strategic objectives

• Strengthening work-sharing initiatives.
• Expanding a lifecycle approach.
• Supporting regulatory innovation.
• Enhancing stakeholder engagement.
• Continuing to encourage joint applications, particularly those involving all member countries, to achieve the greatest collaborative benefits.